SCHEMBL10501811

SCHEMBL10501811

Cc1ccccc1-n1[se]c2ccccc2c1=S

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MPI P34949 2/20 0.48
▸ PHOSPHO1 Q8TCT1 2/20 0.48
▸ METAP2 P50579 8/20 0.43
▸ ALDH1A1 P00352 3/20 0.39
▸ LMNA P02545 2/20 0.39
▸ TDP1 Q9NUW8 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ QSOX1 O00391 1/20 0.39
▸ RGS12 O14924 1/20 0.39
▸ PMM2 O15305 1/20 0.39
▸ PLIN1 O60240 1/20 0.39
▸ GMNN O75496 1/20 0.39
▸ BBOX1 O75936 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ CYBB P04839 1/20 0.39
▸ BCHE P06276 1/20 0.39
▸ GLA P06280 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10502530 0.89 MPI (0.41) MPIPHOSPHO1METAP2ALDH1A1TDP1
SCHEMBL10501645 0.84 MPI (0.54) MPIPHOSPHO1METAP2ALDH1A1KDM4E
SCHEMBL10502376 0.84 MPI (0.69) MPIPHOSPHO1METAP2ALDH1A1LMNA
SCHEMBL10501737 0.83 METAP2 (0.41) MPIPHOSPHO1METAP2ALDH1A1LMNA
SCHEMBL10501413 0.82 MPI (0.51) MPIPHOSPHO1METAP2ALDH1A1LMNA
SCHEMBL10501742 0.82 METAP2 (0.47) MPIPHOSPHO1METAP2GLA
SCHEMBL10502541 0.82 METAP2 (0.47) MPIPHOSPHO1METAP2ALDH1A1
SCHEMBL10502354 0.79 METAP2 (0.41) MPIPHOSPHO1METAP2ALDH1A1LMNA
SCHEMBL10502616 0.79 METAP2 (0.46) MPIPHOSPHO1METAP2ALDH1A1LMNA
SCHEMBL10501672 0.79 MPI (0.72) MPIPHOSPHO1METAP2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0154851-B1 BENZISOSELENAZOLETHIONES,PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL PRODUCTS CONTAINING THESE COMPOUNDS A. Nattermann & Cie. GmbH (DE) 1989-08-02 — — EP disclosed
US-4711961-A Benzisoselenazolethiones and process for the treatment of various diseases in humans A. NATTERMANN & CIE GMBH (DE) 1987-12-08 — — US disclosed
EP-0154851-A1 Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds A. Nattermann & Cie. GmbH (DE) 1985-09-18 — — EP disclosed
Send feedback